Discover
KURA
Kura Oncology, Inc.
11.73
2 x 8.42
2 x 14.95
bid
ask
+
0.01
0.09%
2 @ 07:30 PM
11.73 +0.00 (0.00%)
| Ytd | 12.90% | |
| 1y | 38.98% |
11.56
day range
11.84
7.40
52 week range
13.59
| Open | 11.61 | Prev Close | 11.72 | Low | 11.56 | High | 11.84 | Mkt Cap | 1.04B |
| Vol | 2.67M | Avg Vol | 1.81M | EPS | -3.37 | P/E | N/A | Forward P/E | -5.11 |
| Beta | 0.43 | Short Ratio | 6.19 | Inst. Own | 99.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 11.18 | 200-d Avg | 9.81 | 1yr Est | 32.00 |
| Income Statement | |||
| Total Revenue | 20.87M | ||
| Revenues (USD) | 20.87M | ||
| Cost of Revenue | 243.00K | ||
| Gross Profit | 20.63M | ||
| Operating Expenses | 93.64M | ||
| Research and Development Expense | 61.89M | ||
| Selling, General and Administrative Expense | 31.75M | ||
| Operating Income | -73.01M | ||
| Interest Expense | 345.00K | ||
| Income Tax Expense | 5.00K | ||
| Net Income | -68.33M | ||
| Net Income Common Stock | -68.33M | ||
| Net Income Common Stock (USD) | -68.33M | ||
| Consolidated Income | -68.33M | ||
| Earnings per Basic Share | -0.77 | ||
| Earnings per Basic Share (USD) | -0.77 | ||
| Earnings per Diluted Share | -0.77 | ||
| Earning Before Interest & Taxes (EBIT) | -67.98M | ||
| Earning Before Interest & Taxes (USD) | -67.98M | ||
| Weighted Average Shares | 88.86M | ||
| Weighted Average Shares Diluted | 88.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 70.24M | ||
| Cash and Equivalents (USD) | 70.24M | ||
| Investments | 448.78M | ||
| Investments Current | 448.78M | ||
| Trade and Non-Trade Receivables | 9.45M | ||
| Current Assets | 559.44M | ||
| Property, Plant & Equipment Net | 14.62M | ||
| Total Assets | 587.79M | ||
| Debt Current | 5.51M | ||
| Total Debt | 24.46M | ||
| Current Liabilities | 118.19M | ||
| Debt Non-Current | 18.95M | ||
| Total Liabilities | 539.36M | ||
| Accumulated Retained Earnings (Deficit) | -1.32B | ||
| Accumulated Other Comprehensive Income | -1.21M | ||
| Shareholders Equity | 48.43M | ||
| Shareholders Equity (USD) | 48.43M | ||
| Assets Non-Current | 28.35M | ||
| Total Debt (USD) | 24.46M | ||
| Deferred Revenue | 398.60M | ||
| Inventory | 2.49M | ||
| Liabilities Non-Current | 421.17M | ||
| Trade and Non-Trade Payables | 2.39M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 369.00K | ||
| Net Cash Flow from Financing | 1.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 31.16M | ||
| Capital Expenditure | -656.00K | ||
| Issuance (Purchase) of Equity Shares | 1.50M | ||
| Net Cash Flow from Investing | 92.21M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 92.87M | ||
| Net Cash Flow from Operations | -62.55M | ||
| Share Based Compensation | 8.21M | ||